Dear congress attendees

Dear congress visitors, it is an honor and pleasure to write a few welcome notes. Ophthalmic drugs development has made tremendous progress for the last two decades. Today vision research is continually being transformed by new information and technologies. Many molecular technics, including gene therapy and mRNA technology, make unprecedented progress, to move forward to access to efficient innovative therapies to patients. Additionally, more advanced imaging modalities support our research. This opens new opportunities to prevent and treat blinding eye diseases. The IOC 2026 Scientific Conference will bring eye and vision scientists, researchers, health care professionals, advocacy groups, and patients, all involved in the development of new therapies for ophthalmic diseases, and aims at promising discussions on the latest advancements in Ophthalmology. Please, join us to enrich these discussions!